Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations.
暂无分享,去创建一个
M. Stratton | M. J. van de Vijver | J. Chang-Claude | B. Ponder | J. Struewing | D. Easton | R. Scott | S. Lakhani | J. Peto | B. Gusterson | R. Barkardottir | P. Devilee | U. Hamann | S. Neuhausen | R. McManus | J. Sloane | C. Cornelisse | D. Stoppa-Lyonnet | G. Lenoir | V. Egilsson | N. Haites | D. Bishop | N. Spurr | Y. Bignon | D. Ford | D. Goldgar | B. Weber | H. Sobol | S. Scherneck | T. Anderson | C. Steel | D. Venter | C. Lasset | P. Daly | W. Ormiston | B. Ponder | J. Jacquemier | J. Klijn | A. Storfer‐Isser | J. Jacquemier | E. Smyth | C. Cornelisse | P. Daly | L. Farid | A. Antoniou | Rodney J. Scott | Antonios V. Antoniou | Michael R. Stratton | Barbara L. Weber | M. V. Vijver | M. Stratton | D. Bishop | Linda M. Farid
[1] D. Birnbaum,et al. Novel indications for BRCA1 screening using individual clinical and morphological features , 1999, International journal of cancer.
[2] J. Spratt. Re: Variation in mammographic breast density by time in menstrual cycle among women aged 40-49 years. , 1999, Journal of the National Cancer Institute.
[3] D. Birnbaum,et al. BRCA1 and medullary breast cancer. , 1998, JAMA.
[4] C. Tomasetto,et al. The pS2/TFF1 trefoil factor, from basic research to clinical applications. , 1998, Biochimica et biophysica acta.
[5] J. Thompson,et al. BRCA1 mutations and breast cancer in the general population: analyses in women before age 35 years and in women before age 45 years with first-degree family history. , 1998, JAMA.
[6] J Chang-Claude,et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. , 1998, American journal of human genetics.
[7] H. Ruffner,et al. BRCA1 is a cell cycle-regulated nuclear phosphoprotein. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[8] D E Goldgar,et al. Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13. , 1997, American journal of human genetics.
[9] M. Stratton. Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases , 1997, The Lancet.
[10] Luke Hughes-Davies,et al. Transcriptional activation functions in BRCA2 , 1997, Nature.
[11] G. Eichele,et al. Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2 , 1997, Nature.
[12] A. Ashworth,et al. Cloning, chromosomal mapping and expression pattern of the mouse Brca2 gene. , 1997, Human molecular genetics.
[13] Yonghong Xiao,et al. Association of BRCA1 with Rad51 in Mitotic and Meiotic Cells , 1997, Cell.
[14] A. Berchuck,et al. Cell cycle control of BRCA2. , 1996, Cancer research.
[15] I. Verma,et al. Transcriptional activation by BRCA1 , 1996, Nature.
[16] J. Rommens,et al. The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds , 1996, Nature Genetics.
[17] M. King,et al. Growth retardation and tumour inhibition by BRCA1 , 1996, Nature Genetics.
[18] G M Lenoir,et al. Hereditary breast cancer: Pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage , 1996, Cancer.
[19] Julian Peto,et al. Identification of the breast cancer susceptibility gene BRCA2 , 1996, Nature.
[20] B. Koller,et al. Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities , 1996, Nature Genetics.
[21] D. Birnbaum,et al. Germ line mutation at BRCA1 affects the histoprognostic grade in hereditary breast cancer. , 1996, Cancer research.
[22] C. Larsson,et al. Mutation analysis of the BRCA2 gene in 49 site–specific breast cancer families , 1996, Nature Genetics.
[23] B. Weber,et al. Mouse Brca1: localization sequence analysis and identification of evolutionarily conserved domains. , 1995, Human molecular genetics.
[24] D. Easton,et al. Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. , 1995, American journal of human genetics.
[25] David L. Page,et al. Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression , 1995, Nature Genetics.
[26] Steven E. Bayer,et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. , 1994, Science.
[27] U. Chetty,et al. Breast cancer incidence, penetrance and survival in probable carriers of BRCA1 gene mutation in families linked to BRCA1 on chromosome 17q12–21 , 1994, The British journal of surgery.
[28] S. Seal,et al. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. , 1994, Science.
[29] A. Gentile,et al. Medullary carcinoma of the breast. A multicenter study of its diagnostic consistency. , 1993, Archives of pathology & laboratory medicine.
[30] J. Davies,et al. Pathology reporting in breast cancer screening. Royal College of Pathologists Working Group. , 1991, Journal of clinical pathology.
[31] M. King,et al. Linkage of early-onset familial breast cancer to chromosome 17q21. , 1990, Science.
[32] N. Breslow,et al. Statistical methods in cancer research: volume 1- The analysis of case-control studies , 1980 .
[33] P. Rosen,et al. Medullary carcinoma of the breast. A clinicopathologic study with 10 year follow‐up , 1977, Cancer.
[34] P. J. Huber. The behavior of maximum likelihood estimates under nonstandard conditions , 1967 .
[35] W. W. Richardson. Medullary Carcinoma of the Breast , 1956, British Journal of Cancer.